Rossium Pharmaceuticals is a Russian pharmaceutical company established in 2023 following merging of Rossium Group pharmaceutical assets.

Rossium is a multi-industry finance and investment holding company founded in 2006. The key Rossium Group investments mainly refer to banking and finance sectors, real estate and pharmaceutical industry.

Rossium Pharmaceuticals, LLC incorporate the following pharmaceutical assets of Rossium group: distribution of both pharmaceuticals and medical equipment performed by the company GDP, the company BioImmunity (involved into production of Sputnik V, anti- COVID vaccine) as well as the full service biopharmaceutical company «SAMSON-MED».